Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy Read more
Pulmatrix Enters Into Binding Term Sheet with Cipla Technologies LLC for the Development and Commercialization of Pulmazole Read more
Novartis adds clinical and preclinical anti-inflammatory programs to portfolio with acquisition of IFM Tre Read more
Puma Biotechnology and Pierre Fabre Enter into Exclusive License Agreement to Develop and Commercialize NERLYNX (neratinib) in Europe Read more